About Moderna (MRNA)
Moderna, Inc. is engaged in transformative medicines based on messenger ribonucleic acid (mRNA). It has created a platform to improve the underlying pharmaceutical properties of our mRNA medicines. Its platform consists of three areas: mRNA technolog... Read more
- USD28.83
- USD30.65
- USD28.62
- USD129.39
- 6.10%
- 3.2B
- 14.71M
- 11.85M
- 10.5B
- 23.15
- -75.30%
Stock News
yesterday
Datadog’s stock soars on S&P 500 nod — as the wait continues for Robinhood
MarketWatch
yesterday
Jim Cramer on two trends moving the market: Global trade and dollar weakness
CNBC
yesterday
Oaktree Specialty Lending Corporation Schedules Third Fiscal Quarter Earnings Conference Call for August 5, 2025
Yahoo
yesterday
Trump's deportations are hurting Constellation Brands' beer sales
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
